Plancorp LLC’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $865K | Sell |
2,399
-595
| -20% | -$204K | 0.02% | 197 |
|
|
2026
Q1 | $1.05M | Buy |
2,994
+18
| +0.6% | +$6.42K | 0.03% | 155 |
|
|
2025
Q4 | $974K | Sell |
2,976
-26
| -0.9% | -$8.25K | 0.03% | 156 |
|
|
2025
Q3 | $847K | Sell |
3,002
-154
| -5% | -$44.7K | 0.03% | 166 |
|
|
2025
Q2 | $881K | Buy |
3,156
+84
| +3% | +$23.8K | 0.03% | 161 |
|
|
2025
Q1 | $957K | Buy |
3,072
+43
| +1% | +$12.7K | 0.04% | 151 |
|
|
2024
Q4 | $790K | Buy |
3,029
+224
| +8% | +$66.5K | 0.03% | 148 |
|
|
2024
Q3 | $904K | Buy |
2,805
+41
| +1% | +$13.4K | 0.04% | 137 |
|
|
2024
Q2 | $864K | Buy |
2,764
+6
| +0.2% | +$1.76K | 0.04% | 136 |
|
|
2024
Q1 | $784K | Buy |
2,758
+150
| +6% | +$43.9K | 0.03% | 141 |
|
|
2023
Q4 | $751K | Buy |
2,608
+129
| +5% | +$35.1K | 0.04% | 131 |
|
|
2023
Q3 | $666K | Buy |
2,479
+16
| +0.6% | +$3.99K | 0.04% | 135 |
|
|
2023
Q2 | $547K | Sell |
2,463
-31
| -1% | -$7.19K | 0.03% | 145 |
|
|
2023
Q1 | $603K | Sell |
2,494
-105
| -4% | -$25.8K | 0.03% | 141 |
|
|
2022
Q4 | $683K | Buy |
2,599
+30
| +1% | +$8.04K | 0.04% | 125 |
|
|
2022
Q3 | $579K | Sell |
2,569
-24
| -0.9% | -$5.82K | 0.04% | 134 |
|
|
2022
Q2 | $631K | Sell |
2,593
-34
| -1% | -$8.33K | 0.04% | 132 |
|
|
2022
Q1 | $635K | Buy |
2,627
+89
| +4% | +$20.4K | 0.04% | 131 |
|
|
2021
Q4 | $571K | Sell |
2,538
-67
| -3% | -$14.1K | 0.04% | 137 |
|
|
2021
Q3 | $554K | Buy |
2,605
+177
| +7% | +$40.7K | 0.04% | 127 |
|
|
2021
Q2 | $592K | Sell |
2,428
-50
| -2% | -$12.3K | 0.05% | 117 |
|
|
2021
Q1 | $617K | Buy |
2,478
+39
| +2% | +$9.31K | 0.14% | 108 |
|
|
2020
Q4 | $561K | Buy |
2,439
+253
| +12% | +$58.3K | 0.14% | 108 |
|
|
2020
Q3 | $556K | Sell |
2,186
-365
| -14% | -$90.4K | 0.17% | 96 |
|
|
2020
Q2 | $602K | Buy |
2,551
+67
| +3% | +$15.3K | 0.18% | 84 |
|
|
2020
Q1 | $503K | Buy |
2,484
+299
| +14% | +$65.3K | 0.19% | 86 |
|
|
2019
Q4 | $527K | Buy |
2,185
+184
| +9% | +$40.6K | 0.16% | 101 |
|
|
2019
Q3 | $387K | Buy |
2,001
+23
| +1% | +$4.42K | 0.15% | 111 |
|
|
2019
Q2 | $364K | Sell |
1,978
-7,512
| -79% | -$1.35M | 0.14% | 113 |
|
|
2019
Q1 | $1.8M | Buy |
9,490
+402
| +4% | +$76.8K | 0.68% | 31 |
|
|
2018
Q4 | $1.77M | Sell |
9,088
-235
| -3% | -$45.8K | 0.8% | 27 |
|
|
2018
Q3 | $1.93M | Buy |
9,323
+32
| +0.3% | +$6.31K | 0.76% | 28 |
|
|
2018
Q2 | $1.72M | Sell |
9,291
-127
| -1% | -$22.5K | 0.69% | 34 |
|
|
2018
Q1 | $1.61M | Buy |
9,418
+237
| +3% | +$43.5K | 0.51% | 35 |
|
|
2017
Q4 | $1.59M | Sell |
9,181
-345
| -4% | -$61.1K | 0.52% | 38 |
|
|
2017
Q3 | $1.77M | Sell |
9,526
-4
| -0% | -$709 | 0.52% | 33 |
|
|
2017
Q2 | $1.64M | Sell |
9,530
-880
| -8% | -$143K | 0.49% | 37 |
|
|
2017
Q1 | $1.71M | Buy |
10,410
+44
| +0.4% | +$7.31K | 0.5% | 37 |
|
|
2016
Q4 | $1.51M | Buy |
10,366
+193
| +2% | +$29K | 0.43% | 37 |
|
|
2016
Q3 | $1.7M | Buy |
+10,173
| New | +$1.72M | 1.08% | 25 |
|
|
2016
Q1 | – | Sell |
-8,186
| Closed | -$1.33M | – | 45 |
|
|
2015
Q4 | $1.33M | Sell |
8,186
-246
| -3% | -$38.7K | 1.59% | 14 |
|
|
2015
Q3 | $1.17M | Buy |
+8,432
| New | +$1.33M | 1.06% | 21 |
|
|
2015
Q2 | – | Sell |
-9,042
| Closed | -$1.45M | – | 79 |
|
|
2015
Q1 | $1.45M | Buy |
+9,042
| New | +$1.42M | 1.44% | 12 |
|
Other funds holding AMGN
Plancorp LLC's AMGN Position: Q2 2026 in Review
Plancorp LLC reduced its Amgen (AMGN) stake by 20% in Q2 2026, selling an estimated $204K and leaving 2,399 shares worth $865K. The position accounts for 0.02% of the portfolio, ranked #197.
Plancorp LLC first reported a position in AMGN in Q1 2015 and has held it in 43 quarters since. The position peaked at $1.93M in Q3 2018. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Plancorp LLC held 2,399 shares of Amgen worth $865K as of Q2 2026.
- Plancorp LLC sold 595 Amgen shares in Q2 2026, an estimated $204K.
- Amgen made up 0.02% of Plancorp LLC's portfolio in Q2 2026, its #197 holding.
- Plancorp LLC first reported a position in Amgen in Q1 2015 and has held it in 43 quarters since.
- Plancorp LLC's Amgen position peaked at $1.93M in Q3 2018.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Plancorp LLC's 13F filing for Q2 2026, filed 14 Jul 2026.